Chronic obstructive pulmonary disease

Lancet

Volumn 352, Issue 9126, 1998, Pages 467-473

  Madison, J Mark ^a   Irwin, Richard S ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ADRENERGIC RECEPTOR STIMULATING AGENT; AMINOPHYLLINE; AMOXICILLIN; ANTIBIOTIC AGENT; BACTERIUM LYSATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CARBOCISTEINE; CEPHALOSPORIN; CORTICOSTEROID; COTRIMOXAZOLE; DOXYCYCLINE; EXPECTORANT AGENT; FLUTICASONE; IPRATROPIUM BROMIDE; MACROLIDE; MUCOLYTIC AGENT; OXYGEN; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; THEOPHYLLINE;

ACUTE RESPIRATORY FAILURE; ANTIBIOTIC THERAPY; BRONCHOSPASM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID THERAPY; ENDOTRACHEAL INTUBATION; HUMAN; IMMUNOTHERAPY; INHALATIONAL DRUG ADMINISTRATION; MUCUS SECRETION; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

EID: 0032497151     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)11081-9     Document Type: Review

References (46)

1. 1 Sherrill DL, Lebowitz MD, Burrows B. Epidemiology of chronic obstructive pulmonary disease. Clin Chest Med 1990; 11: 375-88.
2. 2 Celli BR, Snider GL, Heffner J, et al. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152: S77-120.
3. 3 Siafakas NM, Vermeire P, Pride NB, et al, on behalf of the Task Force. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8: 1398-420.
4. 4 Siafakas NM. ERS consensus statement: optimal assessment and management of chronic obstructive pulmonary disease. Eur Respir Rev 1996; 6: 270-75.
5. 5 Saetta M. Airway pathology of COPD compared with asthma. Eur Respir Rev 1997; 45: 211-15.
6. 6 Pearson MG, Alderslade R, Allen SC, et al. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997; 52 (suppl 5): S1-28.
7. 7 Anthonisen NR, Manfreda J, Warren CPW, Hershfield ES, Harding GKM, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196-204.
8. 8 Recommendations of the immunization practices advisory committee, Center for Disease Control. Ann Intern Med 1987; 107: 521-25.
9. 9 Paggiaro PL, Dahle R, Bakran I, et al. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. Lancet 1998; 351: 73-80.
10. 10 Collet JP, Shapiro S, Ernst P, et al. Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 156: 1719-24.
11. 11 Allegra L, Cordaro CI, Grassi C. Prevention of acute exacerbations of chronic obstructive bronchitis with carbocysteine lysine salt monohydrate: a multicenter, double-blind, placebo-controlled trial. Respiration 1996; 63: 174-80.
12. 12 Repine JE, Bast A, Lankhorst I, and The Oxidative Stress Study Group. Oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 156: 341-57.
13. 13 Smyrnios NA, Irwin RS, Curley FJ. Chronic cough with a history of excessive sputum production. Chest 1995; 108: 991-97.
14. 14 Emerman CL, Effron D, Lukens TW. Spirometric criteria for hospital admission of patients with acute exacerbation of COPD. Chest 1991; 99: 595-99.
15. 15 Murata GH, Gorby MS, Kapsner CO, Chick TW, Halperin AK. A multivariate model for the prediction of relapse after outpatient treatment of decompensated chronic obstructive pulmonary disease. Arch Intern Med 1992; 152: 73-77.
16. 16 Murata GH, Gorby MS, Chick TW, Halperin AK. Use of emergency medical services by patients with decompensated obstructive lung disease. Ann Emerg Med 1989; 18: 501-06.
17. 17 Wilson R. The role of infection in COPD. Chest 1998; 113: 242S-48S.
18. 18 Smith CB, Golden CA, Kanner RE, Renzetti AD. Association of viral and Mycoplasma pneumoniae infections with acute respiratory illness in patients with chronic obstructive pulmonary diseases. Am Rev Respir Dis 1980; 121: 225-32.
19. 19 Monso E, Ruiz J, Rosell A, et al. Bacterial infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152: 1316-20.
20. 20 Irwin RS, Erickson AD, Pratter MR, et al. Prediction of tracheobronchial colonization in current cigarette smokers with chronic obstructive bronchitis. J Infect Dis 1982; 145: 234-41.
21. 21 Epstein RL. The sputum wet prep technique, eosinophils, and reversible obstructive lung disease. Respir Care 1978; 23: 1151-73.
22. 22 Blasi F, Legnani D, Lombado VM, et al. Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur Respir J 1993; 6: 19-22.
23. 23 Eller J, Ede A, Scaberg T, et al. Infective exacerbations of chronic bronchitis. Chest 1998; 113: 1542-48.
24. 24 Saint S, Bent S, Vittinghoff E, Grady D. Antibiotics in chronic obstructive pulmonary disease exacerbations. JAMA 1995; 273: 957-60.
25. 25 Canadian Bronchitis Symposium. Recommendations on the management of chronic bronchitis. Can Med Assoc J 1994; 151 (suppl): 5-23.
26. 26 Grossman RF. The value of antibiotics and the outcomes of antibiotic therapy in exacerbations of COPD. Chest 1998; 113: 249S-55S.
27. 27 Saetta M, Di Stefano A, Maestrelli P, et al. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med 1994; 150: 1646-52.
28. 28 Albert RK, Martin TR, Lewis SW. Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency. Ann Intern Med 1980; 92: 753-58.
29. 29 Thompson WH, Nielsen CP, Carvalho P, Charan NB, Crowley JJ. Controlled trial of oral prednisolone in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med 1996; 154: 407-12.
30. 30 Murata GH, Gorby MS, Chick TW, Halperin AK. Intravenous and oral corticosteroids for the prevention of relapse after treatment of decompensated COPD. Chest 1990; 98: 845-49.
31. 31 Erbland ML, Niewoehner D. Results from SCCOP: systemic corticosteroids in COPD exacerbations trial. Presented at the International Conference for American Lung Association/American Thoracic Society, April 24-29, 1998, Chicago, Illinois.
32. 32 Karpel JP, Pesin J, Greenberg D, Gentry E. A comparison of the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPD. Chest 1990; 98: 835-39.
33. 33 Turner MO, Patel A, Ginsburg S, FitzGerald JM. Bronchodilator delivery in acute airflow obstruction. Arch Intern Med 1997; 157: 1736-44.
34. 34 Rice KL, Leatherman JW, Duane PG, et al. Aminophylline for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 107: 305-09.
35. 35 Wrenn K, Slovis CM, Murphy F, Greenberg RS. Aminophylline therapy for acute bronchospastic disease in the emergency room. Ann Intern Med 1991; 115: 241-47.
36. 36 Wanner A, Salathe M, O'Riordan TG. Mucociliary clearance in the airways. Am J Respir Crit Care Med 1996; 154: 1868-902.
37. 37 Kirilloff LH, Owens GR, Rogers RM, Mazzocco MC. Does chest physical therapy work? Chest 1985; 88: 436-44.
38. 38 Irwin RS, French CT, Mike RW. Respiratory adjunct therapy. In: Rippe JM, Irwin RS, Fink MP, Cerra FB, eds. Intensive care medicine, 3rd edn. Boston: Little, Brown and Co, 1996: 773-86.
39. 39 Jeffrey AA, Warren PM, Flenley DC. Acute hypercapnic respiratory failure in patients with chronic obstructive lung disease: risk factors and use of guidelines for management. Thorax 1992; 47: 34-40.
40. 2 on ventilation and blood gases in patients with chronic obstructive pulmonary disease during acute respiratory failure. Am Rev Respir Dis 1980; 122: 747-54.
41. 41 Newman SL, Roussos CS. Function and failure of the ventilatory muscles. In: Simmons DH, ed. Current pulmonology, vol 7. Chicago: Year Book Medical Publishers, 1986: 272-301.
42. 42 Moser KM, Luchsinger PC, Adamson JS, et al. Respiratory stimulation with intravenous doxapram in respiratory failure. N Engl J Med 1973; 288: 427-31.
43. 43 Bott J, Carroll MP, Conway JH, et al. Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive pulmonary disease. Lancet 1993; 341: 1555-57.
44. 44 Brochard L, Mancebo J, Wysocki M, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1995; 333: 817-22.
45. 45 Hillberg RE, Johnson DC. Noninvasive ventilation. N Engl J Med 1997; 337: 1745-52.
46. 46 Elliott MW. Noninvasive ventilation in chronic obstructive pulmonary disease. N Engl J Med 1995; 333: 870-71.